EUVIMEDScopri EUVIMED
Crossref

Inhaled Glucocorticoids During Pregnancy: A Population‐Level Drug Utilization Study in Denmark From 2001 to 2023

Noor Naser Jasim Al-Sagit iD, Per Damkier iD, Erika Björkström Gram iD

Basic & Clinical Pharmacology & Toxicology · 2026-12 · 139 (6)

DOI: 10.1111/bcpt.70336 ↗

At a glance

Journal article in Basic & Clinical Pharmacology & Toxicology, published online on 2026-11-17. Written by Noor Naser Jasim Al-Sagit and 2 co-authors. Institution: Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Major MEDLINE topics: Glucocorticoids, Asthma, Drug Utilization, Anti-Asthmatic Agents. 31 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

We investigated trends of inhaled corticosteroids (ICS) use among pregnant women in Denmark from 2001 to 2023 using aggregated data from the Danish Health Data Authority, where recorded prescription redemptions in the National Prescription Register are linked to pregnancies recorded in the Danish Medical Birth Registry. Use of combination preparations (ICS and beta2‐agonists) increased substantially (from 1.3 to 21 per 1000 pregnant women), corresponding to a 16‐fold increase, while use of single‐agent preparations (ICS) decreased gradually (from 17 to 11 per 1000 pregnant women). Combination preparations became more prevalent than single‐agent preparations in 2020 among pregnant women, reflecting changes in treatment guidelines and recommendations in 2019. ICS use was higher before than during pregnancy in 2001 (22 vs. 18 per 1000 women) but lower before than during pregnancy in 2023 (30 vs. 32 per 1000 women), with the pattern reversing in 2015. Use during pregnancy was highest among the oldest women (≥ 40 years), with some variation over time, while it fluctuated substantially among the youngest women (≤ 19 years) and increased more steadily among women aged 20–39 years. Overall, our results highlight changes in ICS use among pregnant women that are well aligned with national and international asthma guidelines.

Subjects

MeSH terms (MEDLINE)

GlucocorticoidsAsthmaDrug UtilizationAnti-Asthmatic AgentsPractice Patterns, Physicians'Pregnancy ComplicationsFemaleHumansPregnancyDenmarkAdministration, InhalationAdultRegistriesYoung AdultPractice Guidelines as TopicAdrenergic beta-2 Receptor Agonists

Author keywords

asthmadrug utilizationinhaled glucocorticoidspregnancy

Substances

GlucocorticoidsAnti-Asthmatic AgentsAdrenergic beta-2 Receptor Agonists

Authors and institutions

  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.

ORCID profiles: Noor Naser Jasim Al-Sagit, Per Damkier, Erika Björkström Gram

Cite

APA

Al-Sagit, N. N. J., Damkier, P., & Gram, E. B. (2026). Inhaled Glucocorticoids During Pregnancy: A Population‐Level Drug Utilization Study in Denmark From 2001 to 2023. Basic & Clinical Pharmacology & Toxicology, 139(6). https://doi.org/10.1111/bcpt.70336

Vancouver

Al-Sagit NNJ, Damkier P, Gram EB. Inhaled Glucocorticoids During Pregnancy: A Population‐Level Drug Utilization Study in Denmark From 2001 to 2023. Basic & Clinical Pharmacology & Toxicology. 2026;139(6). doi:10.1111/bcpt.70336

BibTeX
@article{AlSagit2026,
  author = {Al-Sagit, Noor Naser Jasim and Damkier, Per and Gram, Erika Björkström},
  title = {Inhaled Glucocorticoids During Pregnancy: A Population‐Level Drug Utilization Study in Denmark From 2001 to 2023},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  volume = {139},
  number = {6},
  doi = {10.1111/bcpt.70336}
}
Start for free →